Literature DB >> 18181014

"Are you at risk for hereditary breast cancer?": development of a personal risk assessment tool for hereditary breast and ovarian cancer.

Wendy F Cohn1, Susan M Jones, Susan Miesfeldt.   

Abstract

Identification of risk for the hereditary breast and ovarian cancer syndrome (HBOC) is important, as research has demonstrated the benefits of risk-reducing interventions for women with or at risk for this disorder. Knowledge among women regarding risk factors for hereditary breast cancer and the existence of cancer genetics services appears limited. The goal of this project was to develop a tool to broaden women's awareness regarding their potential risk for HBOC. A formal instructional design process was used to develop a brochure to facilitate recognition of HBOC risk among women attending a no-cost breast and cervical cancer screening clinic. Brochure development was guided by gathering feedback from potential users early and often. The resulting brochure included four parts: (1) a brief description of the impact of hereditary breast cancer risk on one's health; (2) a personal and family history collection table; (3) a series of questions enabling the user to self-assess HBOC risk; (4) a list of resources for women at risk for HBOC. User feedback indicated that the brochure was easy to use. The project demonstrated that women can self-evaluate their risk for HBOC. Future work will evaluate this tool among a broader population of women.

Entities:  

Mesh:

Year:  2008        PMID: 18181014     DOI: 10.1007/s10897-007-9125-0

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  68 in total

1.  Primary care physicians' attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results.

Authors:  Lois C Friedman; H Paul Cooper; John A Webb; Armin D Weinberg; Sharon E Plon
Journal:  J Cancer Educ       Date:  2003       Impact factor: 2.037

2.  Testing for inherited susceptibility to breast cancer: a survey of informed consent forms for BRCA1 and BRCA2 mutation testing.

Authors:  S J Durfy; T E Buchanan; W Burke
Journal:  Am J Med Genet       Date:  1998-01-06

3.  Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample.

Authors:  K A Donovan; D C Tucker
Journal:  J Behav Med       Date:  2000-02

4.  Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population.

Authors:  Francisco J Dominguez; Julie L Jones; Katherina Zabicki; Barbara L Smith; Michele A Gadd; Michele Specht; Daniel B Kopans; Richard H Moore; James S Michaelson; Kevin S Hughes
Journal:  Cancer       Date:  2005-11-01       Impact factor: 6.860

5.  What do cancer survivors believe causes cancer? (United States).

Authors:  Kimberly S Wold; Tim Byers; Lori A Crane; Dennis Ahnen
Journal:  Cancer Causes Control       Date:  2005-03       Impact factor: 2.506

6.  An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility.

Authors:  M J Green; B B Biesecker; A M McInerney; D Mauger; N Fost
Journal:  Am J Med Genet       Date:  2001-09-15

7.  Education about genetic testing for breast cancer susceptibility: patient preferences for a computer program or genetic counselor.

Authors:  M J Green; A M McInerney; B B Biesecker; N Fost
Journal:  Am J Med Genet       Date:  2001-09-15

8.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

9.  Informed consent documents for BRCA1 and BRCA2 screening: how large is the readability gap?

Authors:  J N Gribble
Journal:  Patient Educ Couns       Date:  1999-11

10.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

View more
  7 in total

Review 1.  What characterizes cancer family history collection tools? A critical literature review.

Authors:  J E Cleophat; H Nabi; S Pelletier; K Bouchard; M Dorval
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

2.  Literacy assessment of family health history tools for public health prevention.

Authors:  C Wang; R E Gallo; L Fleisher; S M Miller
Journal:  Public Health Genomics       Date:  2010-01-04       Impact factor: 2.000

Review 3.  Family history tools for primary care: A systematic review.

Authors:  Špela Miroševič; Zalika Klemenc-Ketiš; Borut Peterlin
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

4.  Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies.

Authors:  Anita Yeomans Kinney; Amanda Gammon; James Coxworth; Sara E Simonsen; Maritza Arce-Laretta
Journal:  Genet Med       Date:  2010-02       Impact factor: 8.822

5.  Patient interest in recording family histories of cancer via the Internet.

Authors:  Christian Simon; Louise Acheson; Christopher Burant; Nancy Gerson; Sarah Schramm; Susan Lewis; Georgia Wiesner
Journal:  Genet Med       Date:  2008-12       Impact factor: 8.822

6.  Incorporating cancer risk information into general practice: a qualitative study using focus groups with health professionals.

Authors:  Juliet A Usher-Smith; Barbora Silarova; Alison Ward; Jane Youell; Kenneth R Muir; Jackie Campbell; Joanne Warcaba
Journal:  Br J Gen Pract       Date:  2017-02-13       Impact factor: 5.386

7.  The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.

Authors:  Louisa L Lo; Ian M Collins; Mathias Bressel; Phyllis Butow; Jon Emery; Louise Keogh; Prue Weideman; Emma Steel; John L Hopper; Alison H Trainer; Gregory B Mann; Adrian Bickerstaffe; Antonis C Antoniou; Jack Cuzick; Kelly-Anne Phillips
Journal:  JMIR Form Res       Date:  2018-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.